Goodman 1989.

Methods	Design: RCT parallel group, Blindness: double (but in fact triple) Duration of study: 6 wks
Participants	Single or multicentre: Multicentre Diagnostic criteria: DSM III Co‐morbidity allowed: Secondary depression including sever Setting: Outpatients Age: Mean (SD) 39(14) to 35(11) Other characteristics: Men and women
Interventions	No. of arms: Two ‐ Fluvoxamine versus placebo
Outcomes	Primary: Change in YBOCS total score Proportion of responders (defined as CGI of 1 or 2)
Notes	3
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment?	Unclear risk	B ‐ Unclear